Additionally, IHC staining of 30 pairs of cancerous and para-cancerous tissues from PAAD patients showed that RBM10 expression was reduced by approximately 15% in pancreatic cancer tissues compared to para-cancerous tissues (P < 0.05) (Figure 1I, J). Here, RBM10 is linked to pancreatic adenocarcinoma.